Adicet Bio (ACET) News Today $0.62 +0.01 (+1.14%) Closing price 07/3/2025 03:56 PM EasternExtended Trading$0.62 0.00 (0.00%) As of 07/3/2025 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACET Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Adicet Bio, Inc. (ACET) Balance Sheet - Yahoo FinanceJune 28, 2025 | finance.yahoo.comAdicet Bio, Inc. (ACET) Balance Sheet - Yahoo FinanceJune 28, 2025 | finance.yahoo.comAdicet Bio, Inc. (NASDAQ:ACET) Short Interest Up 32.1% in MayJune 17, 2025 | marketbeat.comAdicet Bio, Inc. (NASDAQ:ACET) Receives Average Rating of "Moderate Buy" from BrokeragesJune 11, 2025 | marketbeat.comAdicet Bio’s SWOT analysis: gamma-delta T cell therapy stock faces pivotal yearMay 28, 2025 | uk.investing.comAdicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 19, 2025 | marketbeat.comAdicet Bio (NASDAQ:ACET) Coverage Initiated at StockNews.comMay 18, 2025 | marketbeat.comAdicet Bio (ACET) to Release Earnings on TuesdayMay 8, 2025 | marketbeat.comAdicet Bio Stock Price, Quotes and Forecasts | NASDAQ:ACET | BenzingaMay 8, 2025 | benzinga.comAdicet Bio Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 6, 2025 | businesswire.comAdicet Bio, Inc. (NASDAQ:ACET) Short Interest UpdateMay 3, 2025 | marketbeat.comAdicet Bio (NASDAQ:ACET) Upgraded at StockNews.comApril 30, 2025 | marketbeat.comAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 30, 2025 | businesswire.comAdicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual MeetingApril 28, 2025 | businesswire.comWe're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn RateApril 27, 2025 | finance.yahoo.com12 Health Care Stocks Moving In Thursday's After-Market SessionApril 18, 2025 | benzinga.comAdicet Bio Appoints Michael Grissinger to the Board of DirectorsApril 17, 2025 | finance.yahoo.comAdicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual ConferenceMarch 31, 2025 | businesswire.comAdicet Bio, Inc. (NASDAQ:ACET) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMarch 29, 2025 | marketbeat.comAdicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to AnalystsMarch 23, 2025 | insidermonkey.comAdicet Bio (NASDAQ:ACET) Receives "Buy" Rating from GuggenheimMarch 22, 2025 | marketbeat.comShort Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 16.9%March 18, 2025 | marketbeat.comAdicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal yearMarch 14, 2025 | investing.comRegeneron Pharmaceuticals Inc. Makes New $931,000 Investment in Adicet Bio, Inc. (NASDAQ:ACET)March 11, 2025 | marketbeat.comAdicet Bio (ACET) Expected to Announce Earnings on TuesdayMarch 11, 2025 | marketbeat.comTruist Financial Reaffirms Their Buy Rating on Adicet Bio (ACET)March 10, 2025 | markets.businessinsider.comAdicet Bio (NASDAQ:ACET) Receives "Neutral" Rating from HC WainwrightMarch 8, 2025 | marketbeat.comAdicet Bio (NASDAQ:ACET) Issues Earnings ResultsMarch 7, 2025 | marketbeat.comAdicet Bio reports Q4 EPS (32c), consensus (35c)March 6, 2025 | markets.businessinsider.comAdicet Bio files $250M mixed securities shelfMarch 6, 2025 | markets.businessinsider.comAdicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company ProgressMarch 6, 2025 | businesswire.comAdicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific MeetingMarch 3, 2025 | finance.yahoo.comAdicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by AnalystsMarch 3, 2025 | marketbeat.comAdicet Bio's (ACET) "Neutral" Rating Reaffirmed at HC WainwrightFebruary 28, 2025 | marketbeat.comAdicet Bio shares rise on FDA Fast Track Designation for ADI-001February 27, 2025 | finance.yahoo.comAdicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)February 27, 2025 | businesswire.comAdicet Bio granted fast track designation for ADI-001 by FDAFebruary 6, 2025 | markets.businessinsider.comAdicet Bio, Inc. (NASDAQ:ACET) Given Consensus Rating of "Moderate Buy" by BrokeragesFebruary 6, 2025 | marketbeat.comAdicet Bio's (ACET) Market Perform Rating Reaffirmed at JMP SecuritiesFebruary 6, 2025 | marketbeat.comAdicet Bio's (ACET) "Neutral" Rating Reiterated at HC WainwrightFebruary 5, 2025 | marketbeat.comAdicet Bio Gets Fast Track Designation For ADI-001 In Refractory Systemic Lupus ErythematosusFebruary 5, 2025 | markets.businessinsider.comAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)January 31, 2025 | businesswire.comAdicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech ConferenceJanuary 29, 2025 | finance.yahoo.comAdicet Bio Provides Corporate Update and Highlights Expected 2025 MilestonesJanuary 8, 2025 | businesswire.comAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)December 31, 2024 | businesswire.comAdicet Bio, Inc. (NASDAQ:ACET) Sees Large Increase in Short InterestDecember 30, 2024 | marketbeat.comAdicet Bio (NASDAQ:ACET) Stock Passes Below 200-Day Moving Average - Time to Sell?December 28, 2024 | marketbeat.comH.C. Wainwright Remains a Hold on Adicet Bio (ACET)December 22, 2024 | markets.businessinsider.comAdicet Bio says 1st patient dosed in Phase1 trial of ADI-270 to treat ccRCCDecember 20, 2024 | markets.businessinsider.comAdicet Bio's (ACET) Neutral Rating Reaffirmed at HC WainwrightDecember 19, 2024 | marketbeat.com Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Email Address ACET Media Mentions By Week ACET Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACET News Sentiment▼0.000.54▲Average Medical News Sentiment ACET News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACET Articles This Week▼22▲ACET Articles Average Week Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADMA News GWW News URI News FAST News WSO News WCC News AIT News BECN News AL News GATX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACET) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adicet Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adicet Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
